Lucira Health, Inc. Increase (Decrease) in Accounts Receivable
Lucira Health, Inc. reported Increase (Decrease) in Accounts Receivable of -$12.92 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2022-11-14
- Lucira Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2022-09-30 was $5.66M, a 33.54% decline year-over-year.
- Lucira Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2022-06-30 was -$30.07M, a 1063.78% decline year-over-year.
- Lucira Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2022-03-31 was $11.49M, a 4728.99% increase year-over-year.
- Lucira Health, Inc. increase (decrease) in accounts receivable for the quarter ending 2021-12-31 was $15.44M.
- Lucira Health, Inc. increase (decrease) in accounts receivable for fiscal 2021 was $27.31M, a 9220.82% increase from fiscal 2020.
- Lucira Health, Inc. increase (decrease) in accounts receivable for fiscal 2020 was $293.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2022-09-30 | $5.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$24.41M derived: sum of 2 quarters · filed 2022-11-14 | -$12.92M 10-Q · filed 2022-11-14 | $2.52M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | -$30.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$18.58M 10-Q · filed 2022-08-15 | -$3.14M derived: sum of 3 quarters · filed 2022-08-15 | $5.38M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | $11.49M 10-Q · filed 2022-05-16 | $26.93M derived: sum of 2 quarters · filed 2022-05-16 | $35.45M derived: sum of 3 quarters · filed 2022-11-14 | $38.56M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | $15.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $23.95M derived: sum of 2 quarters · filed 2022-11-14 | $27.07M derived: sum of 3 quarters · filed 2022-11-14 | $27.31M 10-K · filed 2022-03-31 |
| 2021-09-30 | $8.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $11.63M derived: sum of 2 quarters · filed 2022-11-14 | $11.87M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $3.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $3.36M 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $238.00K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $293.00K 10-K · filed 2022-03-31 |